Expression of pro-inflammatory protein S100A12 (EN-RAGE) in Behçet's disease and its association with disease activity: A pilot study

Annals of Dermatology

Volumn 23, Issue 3, 2011, Pages 313-320

  Han, Eun Chun ^a   Cho, Sung Bin ^a   Ahn, Keun Jae ^b   Oh, Sang Ho ^a   Kim, Jihyun ^a   Kim, Dong Soo ^a   Lee, Kwang Hoon ^a   Bang, Dongsik ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Hallym University   (South Korea)

Author keywords

Beh et's disease; Lnterleukin 8; S100A12

Indexed keywords

EID: 80052089457     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2011.23.3.313     Document Type: Article

References (44)

1. Zouboulis CC. Adamantiades-Behçet disease. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick's dermatology in general medicine. 7th ed. New York: McGraw-Hill, 2007:1620-1626.
2. James DG. Behçet's syndrome. N Engl J Med 1979;301:431-432.
3. Al-Otaibi LM, Porter SR, Poate TW. Behçet's disease: a review. J Dent Res 2005;84:209-222.
4. Kalayciyan A, Zouboulis C. An update on Behçet's disease. J Eur Acad Dermatol Venereol 2007;21:1-10.
5. Chun SI, Su WP, Lee S, Rogers RS 3rd. Erythema nodosum-like lesions in Behçet's syndrome: a histopathologic study of 30 cases. J Cutan Pathol 1989;16:259-265. (Pubitemid 19270240)
6. Demirkesen C, Tüzüner N, Mat C, Senocak M, Büyü kbabani N, Tüzün Y, et al. Clinicopathologic evaluation of nodular cutaneous lesions of Behçet syndrome. Am J Clin Pathol 2001;116:341-346. (Pubitemid 32851966)
7. Jorizzo JL, Abernethy JL, White WL, Mangelsdorf HC, Zouboulis CC, Sarica R, et al. Mucocutaneous criteria for the diagnosis of Behçet's disease: an analysis of clinicopathologic data from multiple international centers. J Am Acad Dermatol 1995;32:968-976.
8. Takeno M, Kariyone A, Yamashita N, Takiguchi M, Mizushima Y, Kaneoka H, et al. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995;38:426-433.
9. Sakane T. New perspective on Behçet's disease. Int Rev Immunol 1997;14:89-96.
10. Sahin S, Akoǧlu T, Direskeneli H, Sen LS, Lawrence R. Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis 1996;55:128-133.
11. Rizzi R, Bruno S, Dammacco R. Behçet's disease: an immune-mediated vasculitis involving vessels of all sizes. Int J Clin Lab Res 1997;27:225-232.
12. Zouboulis CC, May T. Pathogenesis of Adamantiades-Behçet's disease. Med Microbiol Immunol 2003;192:149-155.
13. Pietzsch J, Hoppmann S. Human S100A12: a novel key player in inflammation? Amino Acids 2009;36:381-389.
14. Yang Z, Tao T, Raftery MJ, Youssef P, Di Girolamo N, Geczy CL. Proinflammatory properties of the human S100 protein S100A12. J Leukoc Biol 2001;69:986-994. (Pubitemid 32577902)
15. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999;97:889-901. (Pubitemid 29375048)
16. Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, et al. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum 2004;50:1286-1295. (Pubitemid 38480840)
17. Boussac M, Garin J. Calcium-dependent secretion in human neutrophils: a proteomic approach. Electrophoresis 2000;21:665-672. (Pubitemid 30118236)
18. Foell D, Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum 2004;50:3762-3771. (Pubitemid 39643922)
19. Ye F, Foell D, Hirono Kl, Vogl T, Rui C, Yu X, et al. Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease. Am J Cardiol 2004;94:840-844. (Pubitemid 39221519)
20. Foell D, Ichida F, Vogl T, Yu X, Chen R, Miyawaki T, et al. S100A12 (EN-RAGE) in monitoring Kawasaki disease. Lancet 2003;361:1270-1272. (Pubitemid 36428584)
21. Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, et al. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003;52:847-853. (Pubitemid 36613492)
22. Foell D, Hernández-Rodríguez J, Sánchez M, Vogl T, Cid MC, Roth J. Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis. J Pathol 2004;204:311-316. (Pubitemid 39430091)
23. Foell D, Frosch M, Sorg C, Roth J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta 2004;344:37-51. (Pubitemid 38626135)
24. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001;108:949-955. (Pubitemid 32946067)
25. Hofmann MA, Drury S, Hudson Bl, Gleason MR, Qu W, Lu Y, et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun 2002;3:123-135. (Pubitemid 38961122)
26. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's disease. Lancet 1990;335:1078-1080.
27. Freeman AF, Shulman ST. Kawasaki disease: summary of the American Heart Association guidelines. Am Fam Physician 2006;74:1141-1148.
28. Witowski J, Pawlaczyk K, Breborowicz A, Scheuren A, Kuzlan-Pawlaczyk M, Wisniewska J, et al. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol 2000;165:5814-5821.
29. Leung BP, Culshaw S, Gracie JA, Hunter D, Canetti CA, Campbell C, et al. A role for IL-18 in neutrophil activation. J Immunol 2001;167:2879-2886. (Pubitemid 32768922)
30. Freire Ade L, Bertolo MB, de Pinho AJ Jr, Samara AM, Fernandes SR. Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet's disease. Clin Rheumatol 2004;23:203-205. (Pubitemid 38812196)
31. Gur-Toy G, Lenk N, Yalcin B, Aksaray S, Alii N. Serum interleukin-8 as a serologic marker of activity in Behçet's disease. Int J Dermatol 2005;44:657-660. (Pubitemid 41179607)
32. Durmazlar SP, Ulkar GB, Eskioglu F, Tatlican S, Mert A, Akgul A. Significance of serum interleukin-8 levels in patients with Behçet's disease: high levels may indicate vascular involvement. Int J Dermatol 2009;48:259-264.
33. Todaro M, Zerilli M, Triolo G, lovino F, Patti M, Accardo-Palumbo A, et al. NF-kB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins. Arthritis Rheum 2005;52:2179-2191. (Pubitemid 40994341)
34. Evereklioglu C, Er H, Türköz Y, Cekmen M. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease. Mediators Inflamm 2002;11:87-93. (Pubitemid 34526411)
35. Oztas MO, Onder M, Gurer MA, Bukan N, Sancak B. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behçet's disease. Clin Exp Dermatol 2005;30:61-63. (Pubitemid 40188321)
36. Raziuddin S, al-Dalaan A, Bahabri S, Siraj AK, al-Sedairy S. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol 1998;25:329-333.
37. Akdeniz N, Esrefoglu M, Keleş MS, Karakuzu A, Atasoy M. Serum interleukin-2, interleukin-6, tumour necrosis factoralpha and nitric oxide levels in patients with Behçet's disease. Ann Acad Med Singapore 2004;33:596-599. (Pubitemid 39626965)
38. Kose O, Stewart J, Waseem A, Lalli A, Fortune F. Expression of cytokeratins, adhesion and activation molecules in oral ulcers of Behçet's disease. Clin Exp Dermatol 2008;33:62-69. (Pubitemid 350308528)
39. Ahn SK, Choi EH, Lee SH, Lee S, Lee WS, Bong JP. Immunohistochemical study of Behçet's disease comparision of erythema nodosum-like lesion of Behçet s disease and erythema nodosum. J Wonju Coll Med 1993;6:214-223.
40. Ozoran K, Aydintuǧ O, Tokgöz G, Düzgün N, Tutkak H, Gürler A. Serum levels of interleukin-8 in patients with Behçet's disease. Ann Rheum Dis 1995;54:610.
41. Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, et al. Adamantiades-Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 2000;292:279-284. (Pubitemid 30386437)
42. Lin CY, Lin CC, Hwang B, Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 1992;121:924-926.
43. Suzuki H, Noda E, Miyawaki M, Takeuchi T, Uemura S, Koike M. Serum levels of neutrophil activation cytokines in Kawasaki disease. Pediatr Int 2001;43:115-119. (Pubitemid 32378516)
44. Asano T, Ogawa S. Expression of IL-8 in Kawasaki disease. Clin Exp Immunol 2000;122:514-519. (Pubitemid 32002215)